The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets.
 
Akiko Tateishi
No Relationships to Disclose
 
Hidehito Horinouchi
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Lilly; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Chugai Pharma
Research Funding - A2 Healthcare (Inst); Abbvie (Inst); AstraZeneca (Inst); BMKK (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Ken Takasawa
No Relationships to Disclose
 
Nobuji Kouno
No Relationships to Disclose
 
Takaaki Mizuno
No Relationships to Disclose
 
Yu Okubo
No Relationships to Disclose
 
Yukihiro Yoshida
No Relationships to Disclose
 
Shun-ichi Watanabe
No Relationships to Disclose
 
Mototaka Miyake
No Relationships to Disclose
 
Masahiko Kusumoto
No Relationships to Disclose
 
Koji Inaba
No Relationships to Disclose
 
Hiroshi Igaki
Honoraria - Accuray; Daiichi Sankyo/UCB Japan; Elekta; GE Healthcare; Himedic; Itochu; Varian Medical Systems
Consulting or Advisory Role - HekaBio
Research Funding - Children's Integrated Center for Success; Elekta; HekaBio
 
Yasushi Yatabe
No Relationships to Disclose
 
Masami Mukai
No Relationships to Disclose
 
Katsuya Tanaka
No Relationships to Disclose
 
Naoki Mihara
No Relationships to Disclose
 
Kouya Shiraishi
No Relationships to Disclose
 
Takashi Kohno
Consulting or Advisory Role - Lilly Japan
Research Funding - Chugai Pharma; Sysmex
Patents, Royalties, Other Intellectual Property - Patent fee from ThermoFisher Scientific
 
Yuichiro Ohe
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Celltrion; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Anheart Therapeutics; AstraZeneca; Celltrion; Chugai Pharma; Kyorin; Lilly Japan; Novartis; Ono Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Janssen (Inst); Lilly Japan (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ryuji Hamamoto
No Relationships to Disclose